RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Rohto Pharmaceutical Co Stock

Rohto Pharmaceutical Co Dividend 2024

Rohto Pharmaceutical Co Dividend

31 JPY

Rohto Pharmaceutical Co Dividend yield

0.87 %

Ticker

4527.T

ISIN

JP3982400008

WKN

858075

How much dividend does Rohto Pharmaceutical Co 2024 pay?

According to the latest status from September 2024, Rohto Pharmaceutical Co paid a total of 31 JPY per share in dividends within the last 12 months. With the current Rohto Pharmaceutical Co price of 3,570 JPY, this corresponds to a dividend yield of 0.87 %. A dividend is paid 2 times per year.

0.87 % Dividend Yield=
31 JPY Dividend
3,570 JPY Stock Price

Historical Rohto Pharmaceutical Co Dividends

A dividend is paid 2 times per year. Last year, the payout months were April and October.

PaydateDividend
4/28/202517
10/27/202416
4/28/202415
10/28/202312
4/30/202312
10/29/202220
4/30/202221
10/29/202115
4/30/202115
10/29/202013
4/30/202013
10/27/201913
4/27/201912
10/26/201811
4/28/201811
10/27/201711
4/29/201711
10/28/201610
4/29/201610
10/28/201510
1
2
3
4

Rohto Pharmaceutical Co dividend history and estimates

In 2023, Rohto Pharmaceutical Co paid a dividend amounting to 24 JPY. Dividend means that Rohto Pharmaceutical Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Rohto Pharmaceutical Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Rohto Pharmaceutical Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Rohto Pharmaceutical Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Rohto Pharmaceutical Co Dividend History

DateRohto Pharmaceutical Co Dividend
2027e33.12 undefined
2026e33.13 undefined
2025e33.11 undefined
202431 undefined
202324 undefined
202241 undefined
202130 undefined
202026 undefined
201919 undefined
201822 undefined
201722 undefined
201620 undefined
201520 undefined
201418 undefined
201318 undefined
201216 undefined
201116 undefined
201014 undefined
20097.5 undefined
200812 undefined
200712 undefined
200612.5 undefined
200513.75 undefined

Is the Rohto Pharmaceutical Co Dividend Safe?

Rohto Pharmaceutical Co has been increasing the dividend for 4 years.

Over the past 10 years, Rohto Pharmaceutical Co has increased it by an annual 5.587 %.

Over a five-year period, the distribution increased by 10.286%.

Analysts expect a Dividend Increase of 3.34% for the current fiscal year.

Rohto Pharmaceutical Co dividend payout ratio

In 2023, Rohto Pharmaceutical Co had a payout ratio of 41.33%. The payout ratio indicates the percentage of the company's profits that Rohto Pharmaceutical Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Rohto Pharmaceutical Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Rohto Pharmaceutical Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Rohto Pharmaceutical Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Rohto Pharmaceutical Co Payout Ratio History

DateRohto Pharmaceutical Co Payout ratio
2027e42.33 %
2026e42.08 %
2025e42.66 %
202442.24 %
202341.33 %
202244.4 %
202141 %
202038.6 %
201944.36 %
201854.19 %
201750.25 %
201625.1 %
201526.41 %
201423.34 %
201326.27 %
201223.07 %
201123.7 %
201021.27 %
200914.42 %
200818.82 %
200721.4 %
200622.77 %
200529.57 %

Dividend Details

Understanding Rohto Pharmaceutical Co's Dividend Distributions

Rohto Pharmaceutical Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Rohto Pharmaceutical Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Rohto Pharmaceutical Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Rohto Pharmaceutical Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Rohto Pharmaceutical Co Aktienanalyse

What does Rohto Pharmaceutical Co do?

Rohto Pharmaceutical Co Ltd is a leading Japanese company in the pharmaceutical and cosmetic products industry, founded in 1899. The company was originally established as a small company to manufacture herbal medicine before undergoing several mergers and acquisitions to become the company we know today. Rohto Pharmaceutical's business model focuses on developing and marketing innovative products for health and beauty. The company has a global reputation for its high-quality products that undergo stringent testing to ensure they are safe and effective. Rohto Pharmaceutical has various business divisions. One of the main areas is the pharmaceutical division, which manufactures medications for various ailments, including ophthalmology, pain relief, and skincare. Another important business area is Rohto Pharmaceutical's cosmetics division, which offers a wide range of facial care products, sunscreen, and whitening products. The company is known for its lotions and emulsions that are based on high-quality ingredients such as vitamin C, hyaluronic acid, and collagen. Over the years, Rohto Pharmaceutical has also launched several groundbreaking products. For example, the company developed the world's first eye drop product for dry eyes. Another groundbreaking invention by Rohto is the invention of menthol cooling effects in eye drops, which are intended to provide a refreshing sensation in the eyes. Rohto Pharmaceutical has developed innovative technologies and production facilities with cleanroom laboratories for pharmaceutical and cosmetic products. The company's technological advancements also include the development of hybrid companies that combine the competencies of pharmacists and cosmetologists, facilitating the development of products for the beauty and health sectors. Although Rohto Pharmaceutical has focused its efforts on the Japanese market, the company has also opened branches in other countries, including the USA, Europe, and Asia. As a result, Rohto offers a wide range of products such as menthol spray, sunscreen, and eye drops that are sold worldwide. Conclusion: Rohto Pharmaceutical is a leading provider of pharmaceutical and cosmetic products. The company has built its reputation based on its innovative products, stringent quality controls, and groundbreaking technologies. Rohto Pharmaceutical has a vision that encompasses "building health, creating beauty, and making life easier." By dividing its business into various divisions, the company is able to offer a wide range of health and beauty products to meet customer needs. Rohto Pharmaceutical Co is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Rohto Pharmaceutical Co stock

How much dividend does Rohto Pharmaceutical Co pay?

Over the past 12 months, Rohto Pharmaceutical Co paid a dividend of 31 JPY . This corresponds to a dividend yield of about 0.87 %. For the coming 12 months, Rohto Pharmaceutical Co is expected to pay a dividend of 33.11 JPY.

What is the dividend yield of Rohto Pharmaceutical Co?

The current dividend yield of Rohto Pharmaceutical Co is 0.87 %.

When does Rohto Pharmaceutical Co pay dividends?

Rohto Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Rohto Pharmaceutical Co?

Rohto Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Rohto Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 33.11 JPY are expected. This corresponds to a dividend yield of 0.93 %.

In which sector is Rohto Pharmaceutical Co located?

Rohto Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Rohto Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rohto Pharmaceutical Co from 12/1/2024 amounting to 16 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Rohto Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Rohto Pharmaceutical Co in the year 2023?

In the year 2023, Rohto Pharmaceutical Co distributed 24 JPY as dividends.

In which currency does Rohto Pharmaceutical Co pay out the dividend?

The dividends of Rohto Pharmaceutical Co are distributed in JPY.

Andere Kennzahlen von Rohto Pharmaceutical Co

Our stock analysis for Rohto Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rohto Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.